Moreover, the expression of degranulation markers such as CD107a is usually reduced on the surface of these cells [15], proving the existence of an impairment in the capacity to eliminate infected cells in individuals with severe and critical COVID-19 [17]. This evidence concerns the gene LAMP1 and COVID-19.